Literature DB >> 6616326

Extraction of a substance with calcitonin-like immunoreactivity from pituitary glands of intact and thyroidectomized rats.

H G Bone, B D Catherwood, L J Deftos.   

Abstract

We have previously demonstrated the presence of calcitonin (CT)-like immunoreactivity in the pituitary glands of a number of vertebrate species. Subsequent work by ourselves and others has confirmed this finding by immunohistology and radioimmunoassay (RIA) of pituitary extracts. However, no data have been reported on the site of biosynthesis of the CT-like pituitary peptide, or the relationship of pituitary levels of the substance to experimental alterations of systemic CT levels. In the present study, we measured the content of CT-like peptide in rat pituitaries by using gel filtration chromatography and an RIA, which recognizes rat and human calcitonin. The CT-like peptide has an elution position on gel filtration similar to that of rat and human calcitonin. Its RIA binding appears indistinguishable from that of rat thyroidal CT. Various conditions for extraction were evaluated, and homogenization in acetic acid at 100 degrees C gave the best results. The CT-like content of rat pituitaries was generally 75-125 pg/gland. Presence of CT-like peptide in rat pituitaries was not abolished by prior thyroidectomy. We conclude that the CT-like pituitary peptide is not synthesized in the thyroid, but is similar to thyroidal CT in the characteristics studied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616326     DOI: 10.1007/bf02405104

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  16 in total

1.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.

Authors:  S J Marx; G D Aurbach
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

3.  Radioimmunoassay for bovine calcitonin.

Authors:  L J Deftos; J F Habener; G P Mayer; A E Bury; J T Potts
Journal:  J Lab Clin Med       Date:  1972-03

4.  Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary.

Authors:  L J Deftos; D Burton; B D Catherwood; H G Bone; J G Parthemore; R Guillemin; W B Watkins; R Y Moore
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

5.  Distribution of immunoreactive calcitonin in the rat pituitary gland.

Authors:  W B Watkins; R Y Moore; D Burton; H G Bone; B D Catherwood; L J Deftos
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

6.  Immunohistological studies of artiodactyl and teleost pituitaries with antisera to calcitonin.

Authors:  L J Deftos; D W Burton; W B Watkins; B D Catherwood
Journal:  Gen Comp Endocrinol       Date:  1980-09       Impact factor: 2.822

7.  Reactivity of ACTH and synthetic ACTH peptides with antisera to human calcitonin.

Authors:  B D Catherwood; L J Deftos
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  Distribution of beta-endorphin immunoreactivity in normal human pituitary.

Authors:  G Mendelsohn; R D'Agostino; J C Eggleston; S B Baylin
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

9.  Elevation of calcitonin immunoreactivity in the pituitary and thyroid glands of genetically obese rats (fa/fa).

Authors:  D L Margules; J J Flynn; J Walker; C W Cooper
Journal:  Brain Res Bull       Date:  1979 Sep-Oct       Impact factor: 4.077

10.  Calcitonin-like immunoreactivity in rat and human pituitary glands: histochemical, in vitro, and in vivo studies.

Authors:  C W Cooper; T C Peng; J F Obie; S C Garner
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

View more
  1 in total

1.  Immunoreactive calcitonin in brain regions and pituitary of sheep.

Authors:  S Balabanova; O King; R Nowak; H Sachs; D Leupold
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.